Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs

Authors

Keywords

Journal

Volume 11, Issue 6, Pages 1332-1341

Publisher

American Association for Cancer Research (AACR)

Online

2012-04-25

DOI

10.1158/1535-7163.mct-11-0814

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now